Status and phase
Conditions
Treatments
About
This study aims to evaluate vinorelbine plus capecitabine combined with trastuzumab versus trastuzumab alone as the adjuvant Treatment of HER2 positive patients following neoadjuvant chemotherapy
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
550 participants in 2 patient groups
Loading...
Central trial contact
Zhi-Min Shao; Zhi-Ming Shao, M.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal